BRII-B (02137) Schedules 19 March 2026 Board Meeting to Approve FY 2025 Annual Results

Bulletin Express

03/09

Brii Biosciences Limited (BRII-B, stock code 02137) has notified the market that its board of directors will convene on 19 March 2026.

The meeting’s agenda includes: 1. Reviewing and approving the audited annual results for the financial year ended 31 December 2025. 2. Authorising the publication of the FY 2025 results announcement. 3. Handling other routine corporate matters.

The board currently comprises two executive directors—Dr. Zhi Hong (Chairman) and Dr. Ankang Li—and five independent non-executive directors: Dr. Martin J Murphy Jr, Ms. Grace Hui Tang, Mr. Yiu Wa Alec Tsui, Mr. Gregg Huber Alton and Dr. Taiyin Yang.

The notice was released in Hong Kong on 9 March 2026 and was signed by Chairman Dr. Zhi Hong on behalf of the board.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1177566525"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1177566525\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1177566525?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-09 16:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1177566525","market":"us","top_or_hot":-1,"title":"BRII-B (02137) Schedules 19 March 2026 Board Meeting to Approve FY 2025 Annual Results","media":"Bulletin Express","content":"<p>Brii Biosciences Limited (BRII-B, stock code 02137) has notified the market that its board of directors will convene on 19 March 2026.</p>\n<p>The meeting’s agenda includes:\n1. Reviewing and approving the audited annual results for the financial year ended 31 December 2025.\n2. Authorising the publication of the FY 2025 results announcement.\n3. Handling other routine corporate matters.</p>\n<p>The board currently comprises two executive directors—Dr. Zhi Hong (Chairman) and Dr. Ankang Li—and five independent non-executive directors: Dr. Martin J Murphy Jr, Ms. Grace Hui Tang, Mr. Yiu Wa Alec Tsui, Mr. Gregg Huber Alton and Dr. Taiyin Yang.</p>\n<p>The notice was released in Hong Kong on 9 March 2026 and was signed by Chairman Dr. Zhi Hong on behalf of the board.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRII-B (02137) Schedules 19 March 2026 Board Meeting to Approve FY 2025 Annual Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRII-B (02137) Schedules 19 March 2026 Board Meeting to Approve FY 2025 Annual Results\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-09 16:43</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Brii Biosciences Limited (BRII-B, stock code 02137) has notified the market that its board of directors will convene on 19 March 2026.</p>\n<p>The meeting’s agenda includes:\n1. Reviewing and approving the audited annual results for the financial year ended 31 December 2025.\n2. Authorising the publication of the FY 2025 results announcement.\n3. Handling other routine corporate matters.</p>\n<p>The board currently comprises two executive directors—Dr. Zhi Hong (Chairman) and Dr. Ankang Li—and five independent non-executive directors: Dr. Martin J Murphy Jr, Ms. Grace Hui Tang, Mr. Yiu Wa Alec Tsui, Mr. Gregg Huber Alton and Dr. Taiyin Yang.</p>\n<p>The notice was released in Hong Kong on 9 March 2026 and was signed by Chairman Dr. Zhi Hong on behalf of the board.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02137","symbol_name":"騰盛博藥-B","start_time":0,"source_url":"","article_id":"1177566525","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1177566525","pubTimestamp":1773045787,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Brii Biosciences Limited (BRII-B, stock code 02137) has notified the market that its board of directors will convene on 19 March 2026. The meeting’s agenda includes: 1. Reviewing and approving the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02137":"腾盛博药-B"},"translate_title":"BRII-B(02137)定于2026年3月19日召开董事会批准2025财年年度业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02137":1},"content_text":"Brii Biosciences Limited (BRII-B, stock code 02137) has notified the market that its board of directors will convene on 19 March 2026.\nThe meeting’s agenda includes:\n1. Reviewing and approving the audited annual results for the financial year ended 31 December 2025.\n2. Authorising the publication of the FY 2025 results announcement.\n3. Handling other routine corporate matters.\nThe board currently comprises two executive directors—Dr. Zhi Hong (Chairman) and Dr. Ankang Li—and five independent non-executive directors: Dr. Martin J Murphy Jr, Ms. Grace Hui Tang, Mr. Yiu Wa Alec Tsui, Mr. Gregg Huber Alton and Dr. Taiyin Yang.\nThe notice was released in Hong Kong on 9 March 2026 and was signed by Chairman Dr. Zhi Hong on behalf of the board.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}